These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 24332983)

  • 1. Increased nuchal translucency with normal karyotype and anomaly scan: what next?
    Bakker M; Pajkrt E; Bilardo CM
    Best Pract Res Clin Obstet Gynaecol; 2014 Apr; 28(3):355-66. PubMed ID: 24332983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Birth defects associated with increased nuchal translucency].
    Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
    Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased nuchal translucency in the presence of normal chromosomes: what's next?
    Alamillo CM; Fiddler M; Pergament E
    Curr Opin Obstet Gynecol; 2012 Mar; 24(2):102-8. PubMed ID: 22277886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pregnancy outcome in 1,252 fetuses after nuchal translucency measurement in the 1st trimester].
    Horner E; Holzgreve W; Batucan C; Tercanli S
    Praxis (Bern 1994); 2002 Feb; 91(7):261-5. PubMed ID: 11883361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of nuchal translucency thickening in the fetal chromosome abnormality screening].
    Sun LJ; Wang X; Wu QQ; Ruan Y; Yao L
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):819-23. PubMed ID: 24444557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased nuchal translucency with normal karyotype.
    Souka AP; Von Kaisenberg CS; Hyett JA; Sonek JD; Nicolaides KH
    Am J Obstet Gynecol; 2005 Apr; 192(4):1005-21. PubMed ID: 15846173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
    Bardi F; Bosschieter P; Verheij J; Go A; Haak M; Bekker M; Sikkel E; Coumans A; Pajkrt E; Bilardo C
    Prenat Diagn; 2020 Jan; 40(2):197-205. PubMed ID: 31697852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening.
    Äyräs O; Eronen M; Tikkanen M; Rahkola-Soisalo P; Paavonen J; Stefanovic V
    Acta Obstet Gynecol Scand; 2016 May; 95(5):541-6. PubMed ID: 26918672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age.
    Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
    Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(3):3-10. PubMed ID: 15341249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.
    Kenkhuis MJA; Bakker M; Bardi F; Fontanella F; Bakker MK; Fleurke-Rozema JH; Bilardo CM
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):463-469. PubMed ID: 28397377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype.
    Cha'ban FK; Van Splunder P; Los FJ; Wladimiroff JW
    Prenat Diagn; 1996 Jun; 16(6):537-41. PubMed ID: 8809895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [First trimester ultrasound screening for structural and chromosomal anomalies in multiple pregnancy].
    Markov D; Chernev T; Dimitrova V; Masneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(5):11-8. PubMed ID: 15518278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester screening for structural fetal abnormalities: nuchal translucency sonography.
    Devine PC; Malone FD
    Semin Perinatol; 1999 Oct; 23(5):382-92. PubMed ID: 10551791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical aspects of nuchal translucency measurement.
    Abuhamad A
    Semin Perinatol; 2005 Dec; 29(6):376-9. PubMed ID: 16533650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal thickened nuchal soft tissues may first appear in the second trimester in Down syndrome.
    Zimmer EZ; Blazer S; Linn S; Bronshtein M
    J Clin Ultrasound; 2010 Feb; 38(2):71-4. PubMed ID: 19830827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.